University Hospital of Maastricht (azM)
Maastricht, Netherlands
NCT Number: NCT00409604
To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Maastricht, Netherlands
To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
temporary pacing at the onset of revascularisation
Time frame: 4 & 12 months
Guidant Corporation
Industry
Clinical Evaluation of Pacing During the Onset of Revascularization / Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05853042
Acute Coronary Syndrome, Acute Myocardial Infarction
Minneapolis, Minnesota, United States
View Trial DetailsNCT06457815
Acute Myocardial Infarction
Middlesbrough, Teesside, United Kingdom
View Trial DetailsNCT04938661
Acute Coronary Syndrome, Acute Myocardial Infarction
Minneapolis, Minnesota, United States
View Trial DetailsNCT05149560
Acute Myocardial Infarction
Gothenburg, Sweden
View Trial Details